How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

47,210 results for

Hypertension General Measures

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Diagnosis & Assessment of Hypertension - Home Measurement

Diagnosis & Assessment of Hypertension - Home Measurement III. Home BP Measurement | Hypertension Canada Guidelines Subgroup Members: Mark Gelfer, MD; Lyne Cloutier, RN, PhD; Maxime Lamarre-Cliche, MD; Peter Bolli, MD; Guy Tremblay, MD; Donna McLean, RN, NP, PhD; Alain Milot, MD, MSc; Raj Padwal, MD, MSc; Karen Tran, MD; Raymond R. Townsend, MD Central Review Committee: Stella S. Daskalopoulou, MD MSc DIC PhD (Chair); Kaberi Dasgupta, MD MSc; Kelly B. Zarnke, MD MSc; Kara Nerenberg, MD, MSc (...) in this section) or ambulatory BP monitoring before treatment decisions are made (Grade D). Patients should be advised to purchase and use only home BP monitoring devices that are appropriate for the individual and have met standards of the Association for the Advancement of Medical Instrumentation, the most recent requirements of the British Hypertension Society protocol, or the International Protocol for validation of automated BP-measuring devices. Patients should be encouraged to use devices with data

2018 Hypertension Canada

2. Diagnosis & Assessment of Hypertension - Measuring Blood Pressure

Diagnosis & Assessment of Hypertension - Measuring Blood Pressure I. Accurate Measurement of Blood Pressure | Hypertension Canada Guidelines Subgroup Members: Mark Gelfer, MD; Lyne Cloutier, RN, PhD; Maxime Lamarre-Cliche, MD; Peter Bolli, MD; Guy Tremblay, MD; Donna McLean, RN, NP, PhD; Alain Milot, MD, MSc; Raj Padwal, MD, MSc; Karen Tran, MD; Raymond R. Townsend, MD Central Review Committee: Stella S. Daskalopoulou, MD MSc DIC PhD (Chair); Kaberi Dasgupta, MD MSc; Kelly B. Zarnke, MD MSc (...) or if the mean 24-hour SBP is ≥130 mmHg or the DBP is ≥80 mmHg (Grade C). iv. Using home BP monitoring (see Guidelines in , Home BP Monitoring), patients can be diagnosed as hypertensive if the mean SBP is ≥135 mmHg or the DBP is ≥85 mmHg (Grade C). If the office BP measurement is high and the mean home BP is <135/85 mmHg, it is advisable to either repeat home monitoring to confirm the home BP is <135/85 mmHg or perform 24-hour ABPM to confirm that the mean 24-hour ABPM is <130/80 mmHg and the mean awake

2018 Hypertension Canada

3. General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018. (PubMed)

General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018. In the summer of 2016, delegates from the German Respiratory Society, the German Society of Cardiology and the German Society of Pediatric Cardiology met in Cologne, Germany, to define consensus-based practice recommendations for the management of patients with pulmonary arterial hypertension (PAH). These recommendations were built on the 2015 European (...) Pulmonary Hypertension guidelines aiming at their practical implementation, considering country-specific issues, and including new evidence, where available. To this end, a number of working groups was initiated, one of which was specifically dedicated to general measures (i.e. physical activity/supervised rehabilitation, pregnancy/contraception, elective surgery, infection prevention, psychological support, travel) and supportive therapy (i.e. anticoagulants, diuretics, oxygen, cardiovascular

2018 International journal of cardiology

4. Hypertension General Measures

Hypertension General Measures Hypertension General Measures Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Hypertension General (...) Measures Hypertension General Measures Aka: Hypertension General Measures , Lifestyle Modification in Hypertension , Nonpharmacologic Management of Hypertension II. Prevention: Habit Changes BP may normalize with 10 pound weight loss alone Weight loss of 10 kg (22 lb) may reduce SBP up to 5-20 mmHg consumption moderated (limit to <1 ounce/day) Beer (<24 ounces/day) Wine (<8 ounces/day) Whiskey 100-Proof (<2 ounces/day) Dynamic Aerobic at least 150 minutes per week Three times per week Thirty minutes

2018 FP Notebook

5. The 2012 Canadian Hypertension Education Program recommendations for the management of hypertension: Blood pressure measurement, diagnosis, assessment of risk, and therapy

, Issue 3, Pages 270–287 The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy x Stella S. Daskalopoulou Affiliations Division of General Internal Medicine, McGill University, Montreal, Québec, Canada Correspondence Corresponding author: Dr Stella S. Daskalopoulou, McGill University, McGill University Health Centre, Montreal General Hospital, 1650 Cedar Avenue, B2.101.4, Montreal (...) The 2012 Canadian Hypertension Education Program recommendations for the management of hypertension: Blood pressure measurement, diagnosis, assessment of risk, and therapy The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy - Canadian Journal of Cardiology Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 28

2012 CPG Infobase

6. Hypertension Canada's 2018 guidelines for the management of hypertension in pregnancy

and Gynecology, CHU Sainte Justine, Montr eal, Qu ebec, Canada; l Division of General Internal Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada; m Departments of Medicine, Obstetrics and Gynecology, and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada ABSTRACT We present Hypertension Canada’s inaugural evidence-based Cana- dian recommendations for the management of hypertension in preg- nancy. Hypertension in pregnancy is common, affecting approximately (...) in pregnancy is relatively short (often a few weeks to months) compared with studies of hypertension in nonpregnant pop- ulations. Fourth, the clinical outcomes in studies of hyperten- sion in pregnancy are generally not hard cardiovascular outcomes(ie,cardiovasculareventsorcardiovascularmortality), which are associated with higher grades in the Hypertension Canada grading system (Supplemental Table S1). 8 Studies of hypertension in pregnancy use other clinical outcomes (eg, severe hypertension 160/110 mm

2018 CPG Infobase

7. Examining the use and reporting of outcome measures in studies of rehabilitation in patients with pulmonary hypertension

Examining the use and reporting of outcome measures in studies of rehabilitation in patients with pulmonary hypertension Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any (...) associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Example

2019 PROSPERO

8. Differences in knowledge of hypertension by age, gender, and blood pressure self-measurement among the Israeli adult population<sup>✰</sup>. (PubMed)

Differences in knowledge of hypertension by age, gender, and blood pressure self-measurement among the Israeli adult population. Hypertension (HTN) is the most important risk factor for death and disability worldwide. Hypertensive patients' HTN knowledge was shown to be associated with control of HTN. Understanding factors affecting HTN knowledge might help control HTN.To examine differences in HTN knowledge by age, gender, ethnicity, years of education and whether HTN was diagnosed (...) , and to explore whether HTN knowledge is affected by self-measurement of blood pressure (BP), in Israel's general population.A cross-sectional, descriptive, correlational design was used. A convenience sample of 430 Israeli adults, sampled in community centers across Israel, in four age groups (18-34, 35-49, 50-64, and above 64) were interviewed by 17 registered nurses, using a structured questionnaire with open-ended questions, during March 2017 and March 2018. ANOVA and chi-square tests for assessing

2019 Heart & Lung

9. Nation-wide hypertension screening in Italy: data from May Measurements Month 2017-Europe. (PubMed)

awareness of the consequences of hypertension, a generally increased cardiovascular risk and unsatisfactory BP control in 36% of interviewed individuals. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in May 2017, during the joint MMM and World Hypertension Day events. Blood pressure measurement, the definition of hypertension and statistical analysis followed the standard MMM protocol. Screenings were conducted both in cities and villages, indoor and outdoor, by health (...) Nation-wide hypertension screening in Italy: data from May Measurements Month 2017-Europe. Elevated blood pressure (BP) is a growing burden worldwide, leading to over 10 million deaths each year. May Measurement Month (MMM) is a global initiative organized by the International Society of Hypertension aimed at raising awareness of high BP and to act as a temporary solution to the lack of screening programs worldwide. A similar approach has been used in Italy since 2012, showing inadequate

Full Text available with Trip Pro

2019 European Heart Journal Supplements

10. Reproducibility of the European Society of Hypertension - International Protocol for validation of blood pressure measuring devices in obese patients. (PubMed)

Reproducibility of the European Society of Hypertension - International Protocol for validation of blood pressure measuring devices in obese patients. Electronic devices for blood pressure (BP) measurements need to go through independent clinical validation as recommended by different authorities, both in general and special populations. Reproducibility of such validation protocols is unknown.The aim of this study was to assess the inter-centre reproducibility of the European Society (...) of Hypertension-International protocol (ESH-IP) in patients with large arm circumference at least 32 cm or obesity.Two independent validation studies were performed in parallel according to the ESH-IP protocol in two centres (Serbia and Armenia). The two studies were performed blindly and independently. The ESH-IP criteria were applied for the analysis. The OMRON RS7 wrist oscillometric devices were used in both studies.The distribution of the mean differences values of 5 or less, 10 or less and 15 mmHg

2019 Journal of Hypertension

11. Alarming Prevalence of Emergency Hypertension Levels in the General Public Identified by a Hypertension Awareness Campaign (PubMed)

Alarming Prevalence of Emergency Hypertension Levels in the General Public Identified by a Hypertension Awareness Campaign Hypertension is a major cause of mortality and morbidity today. The "silent" nature of hypertension makes it critical to determine its prevalence and its severity in the general public and to identify strategies to identify people unaware of its presence. A mobile hypertension awareness campaign was created to: (i) determine the prevalence and types of hypertension (...) in an urban North American center, (ii) increase hypertension awareness, and (iii) identify reasons for lack of therapy adherence.Mobile clinics were provided at shopping malls, workplaces, hospitals, and community centres to measure blood pressure in the public. Blood pressure recordings were done on a voluntary basis.Of 1097 participants, 50% presented with high blood pressure which was higher than expected. Of particular clinical significance, an unexpectedly large number of participants (2%) exhibited

Full Text available with Trip Pro

2017 American journal of hypertension

12. Risk for hypertension crosses generations in the community: a multi-generational cohort study. (PubMed)

generations of Framingham Heart Study participants with standardized blood pressure measurements performed at serial examinations spanning 5 decades (1948 through 2005): First Generation (n = 1809), Second Generation (n = 2631), and Third Generation (n = 3608, mean age 39 years, 53% women). To capture a more precise estimate of conferrable risk, we defined early-onset hypertension (age <55 years) as the primary exposure. In multinomial logistic regression models adjusting for standard risk factors as well (...) Risk for hypertension crosses generations in the community: a multi-generational cohort study. Parental hypertension is known to predict high blood pressure (BP) in children. However, the extent to which risk for hypertension is conferred across multiple generations, notwithstanding the impact of environmental factors, is unclear. Our objective was therefore to evaluate the degree to which risk for hypertension extends across multiple generations of individuals in the community.We studied three

Full Text available with Trip Pro

2017 European Heart Journal

13. Diagnosis & Assessment of Hypertension - Renovascular Hypertension

. Hypertension is the most common manifestation, often requiring multiple drugs . Headache, tinnitus, dizziness, neck pain, and cervical/abdominal bruits may also be present . The diagnosis for FMD is based on diagnostic imaging with catheter-based angiography being the ‘gold standard’. Non-invasive imaging modalities include captopril renal scan, duplex ultrasound, computed tomographic angiography and magnetic resonance angiography. Estimates of sensitivity and specificity vary widely and are generally (...) Diagnosis & Assessment of Hypertension - Renovascular Hypertension VII. Assessment for Renovascular Hypertension | Hypertension Canada Guidelines Subgroup Members: Marcel Ruzicka, MD PhD; Sheldon W. Tobe, MD MScCH; Ramesh Prasad, MBBS MSc MA PhD; Michel Vallée, MD PhD; Cedric Edwards, MD Central Review Committee: Stella S. Daskalopoulou, MD MSc DIC PhD (Chair); Kaberi Dasgupta, MD MSc; Kelly B. Zarnke, MD MSc; Kara Nerenberg, MD, MSc; Alexander A. Leung, MD MPH; Kevin C. Harris, MD MHSc; Kerry

2018 Hypertension Canada

14. Diagnosis & Assessment of Hypertension - Endocrine Hypertension

adverse sequelae (stroke, myocardial infarction, arrhythmias, CHF, cardiomyopathy, and particularly abrupt onset of malignant hypertension), and specialized therapeutic interventions, we recommend referral of individuals suspected of having pheochromocytomas/PPGL to centres with experience in their management. Pheochromocytoma/PPGL may present with a wide spectrum of clinical features, including those that are not generally attributed to excess catecholamines . Paroxysmal or severe sustained (...) Meta b 2000;85:1863-7. Brown MA, Cramp HA, Zammit VC, Whitworth JA. Primary hyperaldosteronism: a missed diagnosis in ‘essential hypertensives’? Aust N Z J Med 1996;26:533-8. Hiramatsu K, Yamada T, Yukimura Y, et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hyperrensive patients. Arch Intern Med 1981; 141:1589-93. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF, Jr. Increased

2018 Hypertension Canada

15. Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for pharmacists: an update

compared with office blood pressure measurements. It also has the ability to identify white coat hypertension. 16 The recommended out-of-office measurement method is ambulatory blood pressure monitor - ing (Grade D). Patients can be diagnosed with hypertension if the mean 24-hour ambulatory blood pressure is =130/80 mmHg or the mean awake ambulatory blood pressure is =135/85 mmHg (Grade C). Home blood pressure monitoring can be used as an alternative if ambulatory blood pressure monitoring (...) diagnosis is confirmed, pharmacologic treat- ment should not be initiated (Grade C). Masked hypertension occurs when blood pressure is controlled in the office but elevated when out-of-office measurements are conducted Figure 1 Hypertension diagnostic algorithm Elevated BP Reading No Diabetes Diabetes AOBP or non-AOBP = 130/80 No No No Yes Yes Yes White Coat Hypertension Hypertension No Hypertension 1. ABPM (preferred) Daytime mean = 135/85 24-hour mean = 130/80 OR 2. Home BP Series Mean = 135/85 1

2016 CPG Infobase

16. Hypertension in pregnancy: diagnosis and management

between the woman and the senior obstetrician. [2010] [2010] 1.3.16 If planned early birth is necessary (see recommendation 1.5.7), offer a course of antenatal corticosteroids and magnesium sulfate if indicated, in line with the NICE guideline on preterm labour and birth. [2010, amended 2019] [2010, amended 2019] P Postnatal in ostnatal inv vestigation, monitoring and treatment estigation, monitoring and treatment 1.3.17 In women with chronic hypertension who have given birth, measure blood pressure (...) reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 15 of 54P Postnatal in ostnatal inv vestigation, monitoring and treatment estigation, monitoring and treatment 1.4.10 In women with gestational hypertension who have given birth, measure blood pressure: daily for the first 2 days after birth at least once between day 3 and day 5 after birth as clinically indicated if antihypertensive treatment is changed after birth. [2010] [2010] 1.4.11

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

17. Risk of new-onset metabolic syndrome associated with white-coat and masked hypertension: data from a general population. (PubMed)

Risk of new-onset metabolic syndrome associated with white-coat and masked hypertension: data from a general population. In the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study, clinical and metabolic variables as well as office, home and ambulatory blood pressure (BP) values were simultaneously measured at baseline and after a 10-year follow-up. The study design allowed us to assess the value of selective and combined elevation of different BP phenotypes in predicting new (...) -onset metabolic syndrome (MetS).The present analysis included 1182 participants without MetS at baseline, as defined by the APT III criteria. On the basis of office, 24-h ambulatory BP and home values, participants were divided into four groups: normal, white-coat hypertension (WCH), masked hypertension and sustained hypertension.Compared with participants with in-office and out-of-office normal BP, a greater incidence of new-onset age-adjusted and sex-adjusted MetS was observed in WCH (OR = 1.75

2018 Journal of Hypertension

18. Metabolic syndrome in hypertensive women in the age of menopause: a case study on data from general practice electronic health records. (PubMed)

Metabolic syndrome in hypertensive women in the age of menopause: a case study on data from general practice electronic health records. There is potential for medical research on the basis of routine data used from general practice electronic health records (GP eHRs), even in areas where there is no common GP research platform. We present a case study on menopausal women with hypertension and metabolic syndrome (MS). The aims were to explore the appropriateness of the standard definition of MS (...) to apply to this specific, narrowly defined population group and to improve recognition of women at high CV risk.We investigated the possible uses offered by available data from GP eHRs, completed with patients interview, in goal of the study, using a combination of methods. For the sample of 202 hypertensive women, 47-59 years old, a data set was performed, consisted of a total number of 62 parameters, 50 parameters used from GP eHRs. It was analysed by using a mixture of methods: analysis

Full Text available with Trip Pro

2018 Medical Informatics and Decision Making

19. Maternal blood pressure and hypertensive disorders during pregnancy and childhood respiratory morbidity. The Generation R Study. (PubMed)

Maternal blood pressure and hypertensive disorders during pregnancy and childhood respiratory morbidity. The Generation R Study. Pre-eclampsia is associated with an increased risk of bronchopulmonary dysplasia, wheezing and asthma in later childhood. Currently, there are no studies available investigating maternal blood pressure measurements during multiple time-points in pregnancy and respiratory outcome measures in the child.We examined the associations of maternal blood pressure (...) and hypertensive disorders with the risk of lower lung function, wheezing and asthma in children aged 10 years. This study among 4894 children was embedded in a population-based prospective cohort study. We used multivariate analyses, taking lifestyle and socioeconomic factors into account.We observed consistent associations per 5 mmHg higher maternal blood pressure in early pregnancy with a lower forced expiratory volume in 1 s/forced vital capacity ratio (z-score -0.03 (95% CI -0.05- -0.01)) and per 5 mmHg

2018 European Respiratory Journal

20. Development of a Multistep Hypertension Quality Improvement Program in an Academic General Medicine Practice. (PubMed)

Development of a Multistep Hypertension Quality Improvement Program in an Academic General Medicine Practice. Hypertension is a common problem and a major risk factor for cardiovascular disease. It is unclear whether efforts to control blood pressure (BP) known to be effective in integrated healthcare systems can be successfully implemented in an academic setting. We describe our experience implementing a multistep quality improvement program within an academic general medicine practice aimed (...) at improving BP among patients with uncontrolled hypertension. Ensuring medical assistants were correctly measuring BP provided the basis for accurate data entry into the electronic medical record (EMR); our EMR-based registry data allowed us to feedback primary care provider (PCP) level data on BP control for panel management, which resulted in improvements in BP for a substantial proportion of patients, particularly for those with more practice visits. However, due to PCP, patient, and system barriers

2018 Journal for Healthcare Quality

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>